Koné-Paut I, Geisler I, Wechsler B, Ozen S, Ozdogan H, Rozenbaum M, Touitou I
Department of Pediatrics, Hôpital Nord, Marseilles, France.
J Pediatr. 1999 Jul;135(1):89-93. doi: 10.1016/s0022-3476(99)70333-1.
To examine familial aggregation of Behçet's disease (BD) in pediatric compared with non-pediatric patients.
A retrospective study was conducted to analyze data collected from 572 patients with BD in whom the diagnosis was made with criteria defined by the International Study Group for BD. The age of attaining criteria (the age at which the patient met the study group criteria) was evaluated for each patient. Recurrence risks were calculated for the pediatric group from information provided by 45 families.
Of the 505 patients from whom the age of attaining criteria could be ascertained, 106 showed definitive BD before the age of 16 years and were considered as pediatric patients with BD; the other 399 were classified as non-pediatric patients. Thirteen of the 106 pediatric patients (12.3%) and only 9 of the 399 non-pediatric patients (2.2%) had relatives affected by BD. This excess of familial cases in the pediatric group compared with the non-pediatric group was significant (P <.0001, chi2 analysis). Moreover, the mean age of attaining criteria in familial cases (17. 95 years [SD = 8.62]) was significantly lower than in sporadic cases (27.28 years [SD = 11]; P <.0001, Student t test). The recurrence risk among siblings and parents who met the International Study Group criteria was 0.1.
Our data support the hypothesis of a genetic component in the pathogenesis of BD, and we propose the inclusion of familial history in the definition of pediatric BD.
研究白塞病(BD)在儿科患者与非儿科患者中的家族聚集性。
开展一项回顾性研究,分析从572例BD患者收集的数据,这些患者的诊断依据国际白塞病研究组定义的标准。评估每位患者达到标准的年龄(即患者符合研究组标准的年龄)。根据45个家庭提供的信息计算儿科组的复发风险。
在505例可确定达到标准年龄的患者中,106例在16岁之前确诊为BD,被视为儿科BD患者;另外399例被归类为非儿科患者。106例儿科患者中有13例(12.3%),而399例非儿科患者中只有9例(2.2%)有亲属患BD。与非儿科组相比,儿科组家族性病例的这种超额情况具有显著性(P<.0001,卡方分析)。此外,家族性病例达到标准的平均年龄(17.95岁[标准差=8.62])显著低于散发性病例(27.28岁[标准差=11];P<.0001,Student t检验)。符合国际研究组标准的兄弟姐妹和父母的复发风险为0.1。
我们的数据支持BD发病机制中存在遗传成分的假说,并且我们建议在儿科BD的定义中纳入家族史。